首页>
外国专利>
USE OF HYPOXIA INDUCIBLE FACTOR 2ALPHA FOR CURING NEONATAL RESPIRATORY DISTRESS SYNDROME
USE OF HYPOXIA INDUCIBLE FACTOR 2ALPHA FOR CURING NEONATAL RESPIRATORY DISTRESS SYNDROME
展开▼
机译：使用低氧易感性因子2α引起新生儿呼吸窘迫综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
The current invention relates to the field of hypoxia-induced disorders and more specifically to the use of hypoxia inducible factor 2alpha as a target in a method for the screening for molecules that can be used for the treatment of pulmonary hypertension. The invention further relates to the use of HIF-2alpha and/or of the HIF-2alpha inducible protein VEGF for the treatment of neonatal respiratory distress syndrome.
展开▼
